RALEIGH, N.C., May 5 /PRNewswire/ -- CLOSURE Medical Corporation
(Nasdaq: CLSR), a medical tissue cohesive products company, today announced
that it has named Benny Ward, 36, to the position of Chief Financial Officer
and Vice President of Finance. Mr. Ward had been serving as Acting Chief
Financial Officer since March 2000 upon the resignation of J. Blount Swain who
left the Company to pursue an opportunity with a technology company.
Mr. Ward has served as the Company's Controller since 1996, prior to the
Company's initial public offering. Prior to joining Closure, Mr. Ward was a
Senior Accountant at Price Waterhouse LLP. He is a CPA and holds bachelor
degrees from East Carolina University.
Robert V. Toni, President and CEO said, "Benny has made tremendous
contributions to Closure over the last four years and appointing him to the
CFO role was a natural progression. He has a solid background in financial
analysis and expertise in public company financial reporting. I look forward
to broadening our strong working relationship as Benny assumes his new role at
the Company."
CLOSURE Medical Corporation, headquartered in Raleigh, North Carolina,
develops, manufactures and commercializes medical tissue adhesive products
based on its proprietary cyanoacrylate technology. CLOSURE's nonabsorbable
tissue adhesive products may be used to replace sutures and staples for
certain topical wound closure applications, while its internal tissue adhesive
products, once approved and marketed, could potentially be used for internal
wound closure and management. Currently marketed nonabsorbable tissue
adhesive products include DERMABOND(R)* Topical Skin Adhesive, which is used
to replace sutures and staples for closure of certain lacerations and
incisions, OCTYLDENT(R)* adhesive, which is used as an adjunct in the
treatment of adult periodontal disease; and the NEXABAND(R)* line of topical
adhesives, which are used in veterinary wound closure and management.
* DERMABOND(R)is a trademark of Ethicon, Inc.; SOOTHE-N-SEAL, OCTYLDENT
and NEXABAND are all trademarks of CLOSURE Medical Corporation.
To receive CLOSURE's latest news release and other corporate documents via
fax, at no cost, call 1-800-PRO-INFO, use the Company's symbol CLSR. Or visit
the Financial Relations Board's website at http://www.frbinc.com .
SOURCE CLOSURE Medical Corporation
 back to top
Related links:
http://www.frbinc.com
CONTACT:
Robert V. Toni, President & CEO of CLOSURE
Medical Corporation, 919-876-7800; or General Info, Paul G.
Henning, Analyst Info, Cecelia Heer or Media Info, Deanne Eagle
of The Financial Relations Board, 212-661-8030
|
